市场调查报告书
商品编码
1439432
弹性体帮浦 - 全球市场考量、竞争格局、市场预测 (2030)Elastomeric Pump - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球弹性体帮浦市场规模预计到2023年将达到5.23亿美元,到2030年将达到7.65亿美元,2024-2030年预测期间复合年增长率为6.54%。弹性体帮浦需求的增加主要是由于弹性体帮浦的广泛应用、与其他类型输液帮浦相比产品设计的简单性以及弹性体帮浦在世界各地的可用性,这些都推动了市场的发展。预计在2024- 2030 年预测期内将加强并促进市场成长。
弹性体帮浦市场动态
由于各种原因,弹性体帮浦市场的产品需求正在成长。由于弹性体帮浦在各种应用中的使用量不断增加,预计弹性体帮浦市场在预测期内将会增强。
弹性泵是用于注射药物的医疗设备。根据患者所需的治疗,药物可能包括抗生素、化疗药物、5FU、细胞刺激剂、止痛剂和局部麻醉剂。
弹性帮浦是门诊手术中心和家庭医疗机构中施用化疗药物的首选。此外,使用经过适当测试的弹性体帮浦可以减少化疗药物的浪费。
弹性帮浦被肿瘤学和血液学药剂师和技术人员广泛使用。它也广泛受到患者的青睐,因为它可以显着降低治疗成本。
弹性泵用于各个领域,例如术前和术后疼痛管理。在术后早期,必须每天评估疼痛程度和治疗併发症以调整镇痛药,从而增加了对可调整剂量的医疗设备的需求。
因此,弹性体泵在各个领域的使用不断增加,将增加对弹性体泵的需求,也将促进弹性体泵市场的成长。
然而,药物输送准确率的问题以及未能检测到异常药物输送率可能成为弹性体帮浦市场成长的一定限制因素。
持续的 COVID-19 大流行对弹性体帮浦市场产生了轻微影响,因为与冠状病毒患者相比,癌症和其他疾病患者的住院优先顺序较低。此外,在大流行期间,选择性手术暂时停止。然而,随着许多人接种疫苗,弹性体帮浦市场正在恢復势头。
弹性帮浦市场细分分析
就弹性体帮浦市场的产品类型细分而言,在预测期内(2024-2030年),连续速度弹性体输液帮浦预计将在弹性体帮浦市场中占据较高份额。这是由于与这些设备相关的各种好处。
预计在预测期内,对连续速度弹性输液帮浦的需求将会增加。这是由于弹性体帮浦技术的进步。
例如,弹性体帮浦是门诊抗生素治疗的首选,因为它们不需要外部管道。
弹性泵还具有技术进步,可实现更长的储存和稳定性规格,因为这些设备可以轻鬆冷藏和冷冻。
因此,连续速弹性输液帮浦领域的技术进步将增加对连续速弹性输液帮浦的需求,这将推动弹性帮浦市场的成长。
预计北美将主导整个弹性体帮浦市场。
在所有地区中,北美预计将在全球弹性体帮浦市场中占据最大份额。癌症和心血管疾病等慢性病盛行率的增加将增加北美对用于向美国患者给药的弹性泵的需求,从而导致整个弹性泵市场的成长。
本报告提供了全球弹性帮浦市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。
Elastomeric Pumps Market By Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable-Rate Elastomeric Infusion Pumps, Both), By Channel Type (Single Channel, Dual Channel), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to wide application areas and affordability of elastomeric pumps
Global Elastomeric Pumps Market was valued at USD 523 Million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 765 Million by 2030. The increase in demand for Elastomeric Pumps is primarily attributed to the wide application areas of elastomeric pumps, simplicity in product design compared to other types of infusion pumps, affordability of elastomeric pumps across the world are anticipated to bolster the market, thereby contributing to the growth of the Elastomeric Pumps market during the forecast period from 2024-2030.
Elastomeric Pumps Market Dynamics:
The Elastomeric Pumps market is witnessing a growth in product demand owing to various reasons. The increasing use of elastomeric pumps in various applications is anticipated to bolster the market for elastomeric pumps during the forecasted period.
An elastomeric pump is a medical device that is used for the infusion of medication. Depending on the therapy that is required by the patient, the medications comprise antibiotics, chemotherapy, 5FU, cytostatic, analgesics, and local anesthetics.
The elastomeric pumps are continuously been preferred for the administration of chemotherapeutic drugs at ambulatory surgical centers and home care settings. This also increased reduction in the wastage of chemotherapeutic drugs when being used after properly tested elastomeric pumps.
Elastomeric pumps are widely used by oncology and hematology pharmacists and technicians. The devices are also preferred by patients widely owing to a considerable reduction of their treatment costs.
Elastomeric pumps had found their use in various areas of application comprising of both pre and post-operative pain management. In the early days after post-operative surgeries, there is a daily assessment upon the aspect of pain severity and complications of treatment, in order to adjust the analgesic medications, thereby increasing the need for such medical devices that can adjust medication doses.
Thus, due to the increasing utilization of elastomeric pumps in various areas of application, there will be a rising demand for elastomeric pumps, in turn increasing the elastomeric pumps market growth.
However, problems in the accurate rate of drug delivery and failure in the detection of an abnormal rate of drug delivery may be certain limiting factors of the Elastomeric Pumps market growth.
The ongoing Coronavirus disease 2019 (COVID-19) pandemic has slightly impacted the market for elastomeric pumps as hospital admissions for patients suffering from cancers and other disorders were not a priority in comparison to the patients suffering from Coronavirus. Furthermore, elective surgeries were temporarily stopped during the pandemic. However, with masses being vaccinated, the Elastomeric Pumps market has picked momentum.
Elastomeric Pumps Market Segment Analysis:
Elastomeric Pumps Market By Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, Both), By Channel Type (Single Channel, Dual Channel), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Elastomeric Pumps market, the Continuous Rate Elastomeric Infusion Pumps are estimated to hold a higher share in the Elastomeric Pumps market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices.
The demand for continuous rate elastomeric infusion pumps is expected to increase during the forecasted period. This is owing to the rising technological advancements of elastomeric pumps.
For instance, elastomeric pumps are preferred in usage for offering outpatient antibiotic therapy, as these devices do not require any external tubing.
Elastomeric pumps also comprise technological advancements that enable longer storage and stability specifications as these devices can be readily refrigerated and frozen.
Thus, owing to the technological advancements in the area of continuous rate elastomeric infusion pumps, there will be an increase in the demand for continuous rate elastomeric infusion pumps, which in turn will drive the Elastomeric Pumps market growth.
North America is expected to dominate the overall Elastomeric Pumps Market:
Among all the regions, North America is expected to account for the largest share in the global Elastomeric Pumps market. Growing incidence of chronic diseases such as cancer, and cardiovascular diseases will increase the demand for elastomeric pumps in North America for administering drugs to patients in the United States, leading to a rise in the overall elastomeric pumps market growth.
For instance, as per the National Cancer Institute 2020, an estimated number of 1,806,590 new cases were diagnosed in the United States and about 606,520 patients will die from the disease.
Also, as per the American Cancer Society, 2020, an estimated number of 1.8 million new cancer cases were diagnosed in the United States.
Also, as per the Centers for Disease Control and Prevention, in the year 2018, 1,708,921 new cases were reported in the United States. As per the same source, for every 100,000 people, 436 new cancer cases were documented and about 149 patients were affected with cancer.
Furthermore, as per the Centers for Disease Control and Prevention, in 2022, about 659,000 people in the United States were affected with heart disorders every year.
Thus, all the above-mentioned factors are anticipated to propel the market for Elastomeric Pumps in the United States.
Elastomeric Pumps Market Key Players:
Some of the key market players operating in the Elastomeric Pumps market include B.Braun Melsungen AG, Nipro Corporation, HEKA s.r.l., Surgika, Baxter, Daiken Medical Co., Ltd, I-Flow Corp., Gamastech Innovative Infusion Systems, Samtronic Industria e Comercio LTDA, Vikymed Italia s.r.l, PAJUNK, Wolf Medical Supply, Ace Medical Co. Ltd., Leventon, S.A.U., Smiths Medical, Assut Europe, Bexen medical, MULTIMEDICAL S.r.l., Ambu Inc., Canox MD. Srl, among others.
Recent Developmental Activities in the Elastomeric Pumps Market:
In March 2022, Fresenius Kabi announced its 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its wireless Agilia® Connect Infusion System which includes the Agilia® Volumetric Pump and the Agilia® Syringe Pump with Vigilant® Software Suite-Vigilant® Master Med technology.
Key Takeaways from the Elastomeric Pumps Market Report Study
Target Audience who can be benefited from this Elastomeric Pumps Market Report Study
Frequently Asked Questions for Elastomeric Pumps Market:
An elastomeric pump is a medical device that is used for the infusion of medication. Depending on the therapy that is required by the patient, the medications comprise antibiotics, chemotherapy, 5FU, cytostatic, analgesics, and local anesthetics.
Global Elastomeric Pumps Market was valued at USD 523 Million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 765 Million by 2030.
The Elastomeric Pumps market is witnessing a positive market growth owing to the wide application areas of elastomeric pumps, simplicity in product design compared to other types of infusion pumps, affordability of elastomeric pumps across the world are anticipated to bolster the market.
Some of the key market players operating in the Elastomeric Pumps market include B.Braun Melsungen AG, Nipro Corporation, HEKA s.r.l., Surgika, Baxter, Daiken Medical Co., Ltd, I-Flow Corp., Gamastech Innovative Infusion Systems, Samtronic Industria e Comercio LTDA, Vikymed Italia s.r.l, PAJUNK, Wolf Medical Supply, Ace Medical Co. Ltd., Leventon, S.A.U., Smiths Medical, Assut Europe, Bexen medical, MULTIMEDICAL S.r.l., Ambu Inc., Canox MD. Srl and others.
North America is expected to hold the highest share in the revenue in the Elastomeric Pumps market during the forecast period. Growing incidence of chronic diseases such as cancer, and cardiovascular diseases will increase the demand for elastomeric pumps in North America for administering drugs to patients in the United States, leading to a rise in the overall elastomeric pumps market growth in this region.